Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients-Reference-Cited by-同舟云学术

Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients

Published:2015-07-17 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Dodova Rumyana Ivanova,Mitkova Atanaska Velichkova,Dacheva Daniela Rosenova,Hadjo Lina Basam,Vlahova Alexandrina Ivanova,- Hadjieva Margarita Stoyanova Taushanova,Valev Spartak Stoyanov,Caulevska Marija Mitko,Popova Stanislava Dimitrova,Popov Ivan Emilov,Dikov Tihomir Iliichev,Sedloev Theophil Angelov,Ionkov Atanas Stefanov,Timcheva Konstanta Velinova,Christova Svetlana Liubomirova,Kremensky Ivo Marinov,Mitev Vanio Ivanov,Kaneva Radka Petrova

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/s12885-015-1516-2/fulltext.html

Reference47 articles.

1. GLOBOCAN 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 23 Jan 2015.

2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

3. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.

4. Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (Review). Oncol Rep. 2013;30(3):1019–29.

5. Balmaña J, Díez O, Rubio IT, Cardoso F, ESMO Guidelines Working Group. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol Suppl. 2011;6:vi31–vi4.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population;International Journal of Molecular Sciences;2024-08-28

2. Detection of receptor for advanced glycation end products (RAGE) and high mobility group protein box 1 HMGB1 levels in patients’ serum with breast cancer;Medical Journal of Babylon;2023-10

3. Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation;International Journal of Immunogenetics;2023-07-28

4. Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients;BMC Cancer;2022-11-02

5. Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations;Familial Cancer;2022-05-21